While many people may meet the criteria for a GLP-1 weight loss clinical trial, some individuals may not be eligible due to safety concerns or study-specific exclusions
This resulted from ectopic storage of fat in the heart, where cardiomyocyte TAG levels were found to have increased twentyfold by 12 weeks of age
However, this side effect typically improves after several weeks of use
[DOI] [PubMed] [Google Scholar] 91.Kosiborod M.N., Abildstrm S.Z., Borlaug B.A., Butler J., Rasmussen S., Davies M., Hovingh G.K., Kitzman D.W., Lindegaard M.L., Mller D.V., et al
Sjoholm, K
Outside of Russia, epithalon is available to licensed researchers as a reference material and is not intended for human use